65
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Noncovalent interaction-assisted drug delivery system with highly efficient uptake and release of paclitaxel for anticancer therapy

, , &
Pages 7039-7051 | Published online: 25 Sep 2017

References

  • WangTHWangHSSoongYKPaclitaxel-induced cell death: where the cell cycle and apoptosis come togetherCancer200088112619262810861441
  • RowinskyEKClinical pharmacology of TaxolJ Natl Cancer Inst Monogr199315152537
  • DuAWLuHStenzelMStabilization of paclitaxel-conjugated micelles by cross-linking with cystamine compromises the antitumor effects against two- and three-dimensional tumor cellular modelsMol Pharm201613113648365927654333
  • SurapaneniMSDasSKDasNGDesigning paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challengesISRN Pharmacol20122012462313962314322934190
  • YoshizawaYKonoYOgawaraKIKimuraTHigakiKPEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacyInt J Pharm20114121–213214121507344
  • ChangHYehMKClinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyInt J Nanomedicine20127496022275822
  • KimSCKimDWShimYHIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacyJ Control Release2001721–319120211389998
  • KimTYKimDWChungJYPhase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignanciesClin Cancer Res200410113708371615173077
  • WinKYFengSSIn vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulationBiomaterials200627102285229116313953
  • GanCWChienSFengSSNanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulationCurr Pharm2010162123082320
  • WangYXinDLiuKZhuMXiangJHeparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activityBioconjug Chem200920122214222119950889
  • RanNLeeYMKimJPoly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapyNat Commun2014561833702371424805848
  • SogaONostrumCFVFensMThermosensitive and biodegradable polymeric micelles for paclitaxel deliveryJ Control Release2005103234135315763618
  • LiGLiuJPangYPolymeric micelles with water-insoluble drug as hydrophobic moiety for drug deliveryBiomacromolecules20111262016202621568262
  • OsadaKCabralHMochidaYBioactive polymeric metallosomes self-assembled through block copolymer–metal complexationJ Am Chem Soc201213432131721317522834643
  • UlbrichKHoláKŠubrVBakandritsosATučekJZbořilRTargeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studiesChem Rev201611695338543127109701
  • KakinokiAKaneoYTanakaTHosokawaYSynthesis and evaluation of water-soluble poly(vinyl alcohol)-paclitaxel conjugate as a macromolecular prodrugBiol Pharm2008315963969
  • MoktanSRyppaCKratzFRaucherDA thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosisInvest New Drugs201230123624820938714
  • ChoiJSJoBWEnhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in ratsInt J Pharm20042801–222122715265561
  • DingJChenLXiaoCChenLZhuangXChenXNoncovalent interaction-assisted polymeric micelles for controlled drug deliveryChem Commun201450771127411290
  • SchüttelkopfAWvan AaltenDMPRODRG: a tool for high-throughput crystallography of protein-ligand complexesActa Crystallogr200460Pt 813551363
  • TrottOOlsonAJAutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreadingJ Comput Chem201031245546119499576
  • Van Der SpoelDLindahlEHessBGroenhofGMarkAEBerendsenHJGROMACS: fast, flexible, and freeJ Comput Chem200526161701171816211538
  • PaálKMüllerJHegedûsLHigh affinity binding of paclitaxel to human serum albuminEur J Biochem200126872187219111277943
  • YanXLKhorELimLYChitosan-alginate films prepared with chitosans of different molecular weightsJ Biomed Mater Res200158435836511410893
  • RichardJPMelikovKVivesECell-penetrating peptides. A reevaluation of the mechanism of cellular uptakeJ Biol Chem2003278158559012411431
  • WenderPAMitchellDJPattabiramanKPelkeyETSteinmanLRothbardJBThe design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transportersProc Natl Acad Sci U S A20009724130031300811087855
  • MitchellDJKimDTSteinmanLFathmanCGRothbardJBPolyarginine enters cells more efficiently than other polycationic homopolymersJ Pept Res200056531832511095185
  • FuruhataMKawakamiHTomaKHattoriYMaitaniYIntracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine lengthBioconjug Chem200617493594216848400
  • WeiYLiCZhangLXuXDesign of novel cell penetrating peptides for the delivery of trehalose into mammalian cellsBiochim Biophys Acta2014183871911192024583082
  • AlvesNJStimpleSDHandlogtenMWAshleyJDKiziltepeTBilgicerBSmall-molecule-based affinity chromatography method for antibody purification via nucleotide binding site targetingAnal Chem201284187721772822928545
  • ChiapporiFMerelliIMilanesiLMarabottiAStatic and dynamic interactions between GALK enzyme and known inhibitors: guidelines to design new drugs for galactosemic patientsEur J Med Chem201363542343423517731
  • BeltingMHeparan sulfate proteoglycan as a plasma membrane carrierTrends Biochem Sci200328314515112633994
  • NovikovFNStroganovOVKhaliullinIGMolecular modeling of different substrate-binding modes and their role in penicillin acylase catalysisFEBS J2013280111512623121694
  • SaarKLindgrenMHansenMCell-penetrating peptides: a comparative membrane toxicity studyAnal Biochem200834515565
  • GautamANandaJSSamuelJSTopical delivery of protein and peptide using novel cell penetrating peptide IMT-P8Sci Rep20166262782628827189051
  • KimSHyunSLeeYYanLYuJNon-hemolytic cell penetrating peptides: site specific introduction of glutamine and lysine residues into the α-helical peptide causes deletion of its direct membrane disrupting ability but retention of its cell penetrating abilityBiomacromolecules20161793007301527442521
  • OhDShiraziANNorthupKEnhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclizationMol Pharm20141182845285424978295
  • NanYHSunghaengLHakjunKSongyubSMammalian cell toxicity and candidacidal mechanism of Arg- or Lys-containing Trp-rich model antimicrobial peptides and their D-enantiomeric peptidesPeptides201031101826183120621141
  • El-AndaloussiSJärverPJohanssonHJLangelUCargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative studyBiochem J2007407Pt 228529217627607
  • ShangLNienhausKJiangXNanoparticle interactions with live cells: quantitative fluorescence microscopy of nanoparticle size effectsJ Nanotechnol20145123882397
  • CommissoCDavidsonSMSoydaner-AzelogluRGMacropinocytosis of protein is an amino acid supply route in Ras-transformed cellsNature2013497745163363723665962
  • DaweiXDerekDLinhaiJSamwaysDSKHeDDesigned filamentous cell penetrating peptides: probing supramolecular structure-dependent membrane activity and transfection efficiencyChem Commun201551591175711760
  • JordanMAWendellKGardinerSDerryWBCoppHWilsonLMitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell deathCancer Res19965648168258631019
  • JordanMATosoRJThrowerDWilsonLMechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrationsProc Natl Acad Sci U S A19939020955295568105478
  • ZasadilLMAndersenKAYeumDCytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindlesSci Transl Med20146229229243
  • Carazo-SalasREGrussOJMattajIWKarsentiERan-GTP coordinates regulation of microtubule nucleation and dynamics during mitotic-spindle assemblyNat Cell Biol20013322823411231571
  • PatelLNZaroJLShenWCCell penetrating peptides: intracellular pathways and pharmaceutical perspectivesPharm Res200724111977199217443399
  • TeravetisyanGTünnemannGNowakDCell entry of arginine-rich peptides is independent of endocytosisJ Biol Chem200928463370337819047062
  • HillaireauHCouvreurPNanocarriers’ entry into the cell: relevance to drug deliveryCell Mol Life Sci200966172873289619499185
  • FutakiSNakaseITadokoroATakeuchiTJonesATArginine-rich peptides and their internalization mechanismsBiochem Soc Trans200735Pt 478478717635148
  • ZieglerANerviPDürrenbergerMSeeligJThe cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidenceBiochemistry200544113814815628854
  • FonsecaSBPereiraMPKelleySORecent advances in the use of cell-penetrating peptides for medical and biological applicationsAdv Drug Deliv Rev2009611195396419538995
  • HamaguchiTMatsumuraYSuzukiMNK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBr J Cancer20059271240124615785749
  • SparreboomAVanTONooijenWJBeijnenJHTissue distribution, metabolism and excretion of paclitaxel in miceAnticancer Drugs19967178868742102
  • WangFShenYXuXSelective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicityInt J Pharm2013456110111223968782
  • SomaDKitayamaJIshigamiHKaisakiSNagawaHDifferent tissue distribution of paclitaxel with intravenous and intraperitoneal administrationJ Surg Res2009155114214619328496
  • ChengHZhuJYXuXDActivable cell-penetrating peptide (ACPP) conjugated prodrug for tumor targeted drug deliveryACS Appl Mater Interfaces2015729160611606926161578
  • SuJSunHMengQLong circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancerAdv Funct Mater201626812431252